Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 110Head and Neck Neoplasms 97Nasopharyngeal Carcinoma 36Carcinoma, Non-Small-Cell Lung 21Salivary Gland Neoplasms 17Carcinoma, Squamous Cell 14Laryngeal Neoplasms 12Nasopharyngeal Neoplasms 10Melanoma 10Breast Neoplasms 10Oropharyngeal Neoplasms 9Hypopharyngeal Neoplasms 9Stomach Neoplasms 8Neoplasms 8Esthesioneuroblastoma, Olfactory 8Esophageal Neoplasms 8Prostatic Neoplasms 7Ovarian Neoplasms 7Carcinoma, Renal Cell 7Urinary Bladder Neoplasms 6Tongue Neoplasms 6Small Cell Lung Carcinoma 6Recurrence 6Lung Neoplasms 6Pancreatic Neoplasms 5Neoplasm Metastasis 5Uterine Cervical Neoplasms 4Triple Negative Breast Neoplasms 4Thyroid Neoplasms 4Mouth Neoplasms 4

Interventions

pembrolizumab 4Nivolumab 3atezolizumab 2fludarabine 1epacadostat 1durvalumab 1avelumab 1aldesleukin 1Interleukin-2 1Docetaxel 1Cyclophosphamide 1Carboxylesterase 1ALT-803 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Microsatellite Instability × Docetaxel × Head & Neck × Clear all
NCT03228667 2026-01-14

QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors

ImmunityBio, Inc.

Phase 2 Active not recruiting
40 enrolled
DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Turcot syndrome, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Melanoma, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Microsatellite Instability, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡